Preclinical research News

News from burleson research technologies

Find the latest news and updates from BRT below.

Burleson Research Technologies President Dr. Gary Burleson, and Director of Operations Dr. Victor Johnson, were honored last week with distinguished immunotoxicology awards from the Society of Toxicology at its 2023 annual meeting in Nashville, Tennessee.  Dr. Johnson was named the Immunotoxicology Specialty Section’s Outstanding Senior Immunotoxicologist, which recognizes scientists
Burleson Research Technologies has partnered with SenzaGen in an agreement to market and offer the in vitro GARD test method, making BRT the first U.S. laboratory to offer this service. The GARD method displays a higher accuracy than other available methods and reveals if chemical substances are causing allergies